13F

Stock

Inhibrx Biosciences, Inc.

INBX · held by 5 managers

Reported value

$16M

Holders

5

+0 new · −0 exited

Holders’ est. mark

$261.5K

Price effect on 2 books still in the name

Largest holder

$14.9M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY442.9K$14.9MHeld
BANK OF AMERICA CORP /DE/17.8K$600.6KHeld
BARCLAYS PLC13.5K$453.6K$261.4KAdded$208.7K
Essential Partners LLC2$67$38Added$38
FNY Investment Advisers, LLC250$8Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.